Page 16 - Corona

Covid-19 cases: Delhi govt urges social distancing as cases spike

The rate of hospital admission has also gone slightly up in the national capital, but it is among those who have some sort of co-morbidities or are unvaccinated

Serum Institute explores new-age vaccine delivery systems for growth

The Pune-based company that manufactured the Covid-19 vaccine administered to most Indians is exploring more sophisticated delivery systems

Monkeypox vs Covid-19: Here's all you need to know about the two infections

With non-endemic countries reporting a rampant spike in the number of monkeypox cases, WHO on July 24, 2022, declared monkeypox a global health emergency

At 434, Mumbai logs highest Covid cases since July 9; one dies, 282 recover

Mumbai registered 434 new coronavirus cases, up from 329 a day ago and the highest daily count since July 9, while one more patient succumbed to the infection in the city, the local civic body said.

This needle-free vaccine fights Covid variants better than traditional ones

Due to the constantly emerging new Covid-19 variants, the currently available vaccines may not be as effective

Cipla Q1 net dips 4% to Rs 686 cr, revenue down 2% on tapering Covid sales

Domestic revenue dips 8.4% as Covid-19 share of branded prescription business normalises; North American business up 10% to $155 million

Mylab, firm that makes kits to detect Covid, starts pathology test facility

"We are now getting to 'wet' pathology tests like blood tests etc and we have set up a centre which will have minimal human intervention and maximum automation

Two new studies reveal coronavirus pandemic's controversial origins

The two new studies also bolster the theory that the Coronavirus pandemic emerged from the wild rather than escaping from a lab in China

Bharat Biotech, ExcellGene consortium to develop variant-proof Covid vax

The consortium is developing or designing a new vaccine concept that confers highly cross-reactive protection against numerous SARS-CoV-2 variants of concern

Free Covid-19 vaccination campaign lifted booster dose coverage: Govt

From a daily average of 4.7 lakh doses per day till July 15, the number of precaution shots went up to 20.4 lakh per day (from July 15 till date)

Recovery tracker: Higher workplace attendance, railway freight numbers

Vehicle registrations, aviation numbers are worse than before

China seals off iPhone maker, CNOOC in Shenzhen to battle Covid-19

The lockdown comes as China narrowly escaped an economic contraction in the June quarter, when a series of rolling lockdowns shut businesses nationwide, eroded employment and hurt consumer spending

Assam reports 736 fresh Covid-19 infection, 136 recoveries, one death

Assam on Saturday evening reported as many as 736 fresh COVID-19 cases, the State Health Department informed

West Bengal reports 1,844 fresh Covid-19 infection, seven more deaths

West Bengal on Saturday registered 1,844 new Covid-19 cases, 393 less than the previous day's count, taking the tally to 20,83,572, the health department said in a bulletin

Assam reports 720 fresh Covid-19 infections, two more fatalities

Assam registered 720 fresh COVID-19 cases, pushing the tally to 7,33,212, while the death count mounted to 8,010 with two more fatalities, the National Health Mission (NHM) said in a bulletin

Maharashtra's Thane records 148 new Covid-19 infections, one death

As many as 148 new cases of coronavirus have been detected in Maharashtra's Thane district, taking its infection count to 7,32,947, a health official said on Thursday

Centre asks states to increase testing, vaccination amid recent Covid surge

Reviews Covid-19 situation in nine states where test positivity rates have been rising

Covaxin's booster dose demonstrates immunity, says Bharat Biotech

Pharmaceutical major Bharat Biotech on Wednesday said its COVID-19 vaccine Covaxin has proven to be safe, well-tolerated, and immunogenic in subjects in controlled clinical trials. The study has been accepted and published in Nature Scientific Reports, a high impact factor journal. A press release from the vaccine maker said the study was conducted in 184 subjects, who were randomised 1:1 and received either a booster dose of Covaxin or a placebo, six months after the primary series of two doses. Subjects were evaluated for safety, neutralising antibody responses against variants of concern, binding antibodies against spike protein, RBD, N proteins, and for memory T and B cell responses to demonstrate cell-mediated immunity, it said. Krishna Ella, chairman and managing director, Bharat Biotech, said the team has now demonstrated that Covaxin is a multi-epitope vaccine with antibodies against spike, RBD and N proteins. "Post booster dose, it has proven neutralising antibody respons

Maharashtra's Thane reports 151 fresh Covid-19 infections, 1 death

Maharashtra's Thane district has reported 151 new COVID-19 cases, taking its infection count to 7,32,799, a health official said on Wednesday

Day-1 of free boosters: Citizens queue up to get jabs ahead of festivals

States start compiling need for additional doses, Centre seeks 50 mn doses from GAVI